COX-2 Inhibitors Overused As Short-Term Therapy, Express Scripts Says
Executive Summary
COX-2 inhibitors are over-prescribed for short-term pain and therefore do not achieve the gastrointestinal safety benefit needed to be considered cost-effective, Express Scripts' drug utilization studies conclude
You may also be interested in...
COX-2, NSAID Concomitant Use With GI Protective Drugs Is Similar, Study Says
COX-2 inhibitor patients use gastro-protective drugs at approximately the same rate as patients taking traditional nonsteroidal anti-inflammatory drugs, an Express Scripts-sponsored study suggests
COX-2, NSAID Concomitant Use With GI Protective Drugs Is Similar, Study Says
COX-2 inhibitor patients use gastro-protective drugs at approximately the same rate as patients taking traditional nonsteroidal anti-inflammatory drugs, an Express Scripts-sponsored study suggests
Patent Disputes Do Not Pay Off, Merck Says: Sweet Spot In “Bitter Medicine”
Aggressive patent defensive strategies do not pay off on Wall Street, Merck CEO Ray Gilmartin told Peter Jennings during an ABC News special, "Bitter Medicine: Pills, Profit and the Public Health," which aired May 29